| Oct 30 |
Neurocrine stock jumps 9% on strong Ingrezza sales, stock buyback
|
| Oct 30 |
Neurocrine (NBIX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Oct 30 |
Neurocrine Biosciences, Inc. 2024 Q3 - Results - Earnings Call Presentation
|
| Oct 30 |
Neurocrine Biosciences (NBIX) Q3 Earnings Miss Estimates
|
| Oct 30 |
Neurocrine: Q3 Earnings Snapshot
|
| Oct 30 |
Neurocrine Biosciences bats Q3 revenue estimates, revises guidance
|
| Oct 30 |
Neurocrine Biosciences Reports Third Quarter 2024 Financial Results and Raises 2024 INGREZZA Sales Guidance
|
| Oct 29 |
Neurocrine Biosciences Q3 2024 Earnings Preview
|
| Oct 23 |
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?
|
| Oct 16 |
Is Neurocrine Biosciences, Inc. (NBIX) the Most Promising Biotech Stock According to Hedge Funds?
|
